Stroke prevention: antiplatelet and antithrombolytic therapy.
Diener
H C
HC
Department of Neurology, University of Essen, Essen, Germany. h.diener@uni-essen.de
D000925:Anticoagulants / Q000627:therapeutic use; D001241:Aspirin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D001925:Brain Damage, Chronic / Q000209:etiology / Q000517:prevention & control; D016893:Carotid Stenosis / Q000601:surgery; D002986:Clinical Trials as Topic; D000077144:Clopidogrel; D004176:Dipyridamole / Q000008:administration & dosage / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D016894:Endarterectomy, Carotid; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D005756:Gastritis / Q000139:chemically induced; D006040:Goals; D006470:Hemorrhage / Q000139:chemically induced; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use; D006801:Humans; D002546:Ischemic Attack, Transient / Q000188:drug therapy; D015201:Meta-Analysis as Topic; D015337:Multicenter Studies as Topic; D009503:Neutropenia / Q000139:chemically induced; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D012008:Recurrence; D012306:Risk; D012449:Safety; D016037:Single-Blind Method; D020521:Stroke / Q000150:complications / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control*; D015912:Thrombolytic Therapy; D013988:Ticlopidine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D017211:Treatment Failure; D016896:Treatment Outcome
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight; D010975:Platelet Aggregation Inhibitors; D004176:Dipyridamole; D000077144:Clopidogrel; D013988:Ticlopidine; D001241:Aspirin